In AR-positive prostate cancer cells, CREB5 interacts with and enhances FOXA1 and AR activity thereby regulating a subset of targets such as MYC and genes related to cell cycle, Wnt signaling and EMT [183, 184]. The gene discussed is CREB5; the disease is prostate cancer.